Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety

被引:62
作者
Sullivan, GM
Oquendo, MA
Simpson, N
Van Heertum, RL
Mann, JJ
Parsey, RV
机构
[1] Columbia Univ, Coll Phys & Surg, Div Neurosci, Dept Psychiat, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA
关键词
depression; hypochondriacal; panic; psychic; serotonin(1A); (5-HT1A); somatic;
D O I
10.1016/j.biopsych.2005.05.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The anxious phenotype of the 5-HT1A receptor knockout mouse and the anxiolytic properties of 5-HT1A agonists suggest that the 5-HT1A receptor modulates anxiety. We investigated the relationship of anxiety expressed in major depressive disorder (MDD) to regional 5-HT1A binding. Methods: Positron emission tomography with [carbonyl-C-11]WAY-100635 was used to estimate regional 5-HT1A binding potential (BP) in 28 medication-free MDD subjects. Stepwise linear regression assessed the predictive capacity of three anxiety components, derived from a larger MDD sample and termed psychic, somatic, and motoric anxiety, on regional 5-HT1A BP. Results: Higherpsychic (beta >= .63) and lowersomatic (beta <= - .70) anxiety predicted over 50% of the variance in 5-HT1A BP in multiple cortical regions, but not in amygdala, hippocampus, or autoreceptors of the raphe nuclei. The psychic and somatic anxiety components were not related to depression severity. Comorbid panic disorder was associated with lower cortical and subcortical 5-HT1A BP. Conclusions: The 5-HT1A receptor in the same brain regions has different relationships to psychic anxiety versus somatic anxiety. Lower 5-HT1A BP in panic disorder may be accounted for by higher somatic and lower psychic anxiety. Further study of the pathobiology of these anxiety components may identify distinct therapeutic targets or mechanisms.
引用
收藏
页码:947 / 954
页数:8
相关论文
共 57 条
[1]  
Beck AT, 1961, ARCH GEN PSYCHIAT, V4, P53, DOI DOI 10.1001/ARCHPSYC.1961.01710120031004
[2]   Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine [J].
Bell, C ;
Forshall, S ;
Adrover, M ;
Nash, J ;
Hood, S ;
Argyropoulos, S ;
Rich, A ;
Nutt, DJ .
JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (01) :5-14
[3]   Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 [J].
Bhagwagar, Z ;
Rabiner, EA ;
Sargent, PA ;
Grasby, PM ;
Cowen, PJ .
MOLECULAR PSYCHIATRY, 2004, 9 (04) :386-392
[4]   AGGRESSION IN HUMANS CORRELATES WITH CEREBROSPINAL-FLUID AMINE METABOLITES [J].
BROWN, GL ;
GOODWIN, FK ;
BALLENGER, JC ;
GOYER, PF ;
MAJOR, LF .
PSYCHIATRY RESEARCH, 1979, 1 (02) :131-139
[5]   PET evaluation of [18F]FCWAY, an analog of the 5-HT1A receptor antagonist, WAY-100635 [J].
Carson, RE ;
Lan, LX ;
Watabe, H ;
Der, MG ;
Adams, HR ;
Jagoda, E ;
Herscovitch, P ;
Eckelman, WC .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (05) :493-497
[6]  
Carson William H, 2004, Psychopharmacol Bull, V38, P38
[7]  
Cleary P., 1977, DRUG EXP CLIN RES, V1, P115
[8]   Residual symptoms and comorbidity in panic disorder [J].
Corominas, A ;
Guerrero, T ;
Vallejo, J .
EUROPEAN PSYCHIATRY, 2002, 17 (07) :399-406
[9]   Achieving remission with venlafaxine and fluoxetine in major depression: Its relationship to anxiety symptoms [J].
Davidson, JRT ;
Meoni, P ;
Haudiquet, V ;
Cantillon, M ;
Hackett, D .
DEPRESSION AND ANXIETY, 2002, 16 (01) :4-13
[10]   PET imaging of serotonin 1A receptor binding in depression [J].
Drevets, WC ;
Frank, E ;
Price, JC ;
Kupfer, DJ ;
Holt, D ;
Greer, PJ ;
Huang, YY ;
Gautier, C ;
Mathis, C .
BIOLOGICAL PSYCHIATRY, 1999, 46 (10) :1375-1387